{"ticker": {"uuid": "cc009a99-612e-45b1-bc00-ad709f30b5f4", "symbol": "ILMN", "name": "Illumina Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Is Illumina Inc (ILMN) Overvalued After 4.2% Rally? GF Value Say", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOSTFyN0VyUndBR0lFTVVHVnlSUnRvVGVPeTVQcnZDV2d3T0VRSlhSOVFrWVI1TEhwVnVmTGhOZjhwYzhLSUIweE1uUzA3Vk5QcE01N184d29Hc2ZDOEtUR3VKTGVQX0FQZkdxU3ZsZUdCY0JNaGJ2aDV6ekp0NHoybm9oM1BYeV9UbGU5RWxWNWtYYm1mTmVlMlo1Qm4xR3hMSGxRdUQ5cjJyd3JHS3F3?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-21T22:32:24+00:00", "published_display": "21 Jul 2026 22:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lobbying Update: $300,000 of ILLUMINA INC. lobbying was just disclosed", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQc0V4bDFETERJcTlkV3hBQ1RJRnU0bHppU2FSS1RBQURIaDRJMFV5cWFiZVhrLVl6eUxDMF80SGx4QkhYbmI2NXcxWGJTRGU2MmMtVUFXVExDcDZyWmdjcG1zWENacy0xNXZseV9fenFMT1pqQWIySG1iM09sX0hGMHVXMDBLU3JSNkM1c1JHa0tyNkNGRmFnTEp0NEcxN095QnBvOF82UjFuVWlzLWc?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-21T17:55:00+00:00", "published_display": "21 Jul 2026 17:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eli Lilly (LLY) Joins Illumina Atlas To Map Disease With AI", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/eli-lilly-lly-joins-illumina-221235419.html", "source_name": "Simply Wall St.", "published_at": "2026-07-20T22:12:35+00:00", "published_display": "20 Jul 2026 22:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Faces German Recall Order Over Element Sequencing Patent Ruling", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/illumina-ilmn-faces-german-recall-231748469.html", "source_name": "Simply Wall St.", "published_at": "2026-07-16T23:17:48+00:00", "published_display": "16 Jul 2026 23:17", "sentiment": "negative", "sentiment_pct": 42, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina expands Billion Cell Atlas program with new AI drug developers", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/illumina-expands-billion-cell-atlas-160000451.html", "source_name": "PR Newswire", "published_at": "2026-07-16T16:00:00+00:00", "published_display": "16 Jul 2026 16:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Juno Bio Opens First CLIA-Certified Sequencing Lab Dedicated Entirely to Women's Health, Backed by Ada Ventures, Artesian, Illumina Accelerator, and Entrepreneur First", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/juno-bio-opens-first-clia-131400815.html", "source_name": "PR Newswire", "published_at": "2026-07-16T13:14:00+00:00", "published_display": "16 Jul 2026 13:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Illumina (ILMN) Stock Is Down Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPQjlyMzE3bmxlVW9QWFltXzRya25faHFVaE1qS1Bma3hYSkFDS3VkRi10MURSQVdsSWMzSUVzQU9YbGpIanQzQmgzRURNMEU3VUpFZHJFRnZkeUtmVmJRdTExMmlnMzQ4VldIQzVKZzZjVFd1NWJ1dXp0V1dnemtzenpjUWtuZw?oc=5", "source_name": "Moomoo", "published_at": "2026-07-15T18:36:31+00:00", "published_display": "15 Jul 2026 18:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Element Biosciences Prevails in German Patent Case Against Illumina", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/element-biosciences-prevails-german-patent-120000561.html", "source_name": "Business Wire", "published_at": "2026-07-14T12:00:00+00:00", "published_display": "14 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Inc. stock outperforms competitors on strong trading day", "summary": "Illumina Inc. (ILMN) stock increased by 3.17% to $193.76, outperforming the broader market during a positive trading session. This rise ended a two-day losing streak for the company's shares. The S&P 500 Index and Dow Jones Industrial Average also saw gains, rising 0.81% and 0.27", "url": "https://www.marketwatch.com/data-news/illumina-inc-stock-outperforms-competitors-on-strong-trading-day-8dde6293-118f7d902bf2", "source_name": "MarketWatch", "published_at": "2026-07-09T17:22:00", "published_display": "09 Jul 2026 17:22", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina stock steadies as investors weigh core sequencing demand and regulatory overhang", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQazRaMWdDUXFGc3VYd0sxZXJGMHhSWkY2eWFhX2xabFl4WGlieHBwZzNpUXdjOEZraWNSeFBqdWJvSDJ2Yy1LOVQ5Q2NsV1FSYno5NGtQeEduMGl3dUJ2MWZMcmZ2WDlMWHBHb2RCamtGZEQwazBIUkdFbXU0WGV0WGhJeG9hVWl3ZEhhSWZQN3dOSFVkcktWeG9mMXJVWGpSc0J2M1NoZEg0VFNrSnFyRWptUnFzSFVxOUFYNktWOXk1MWJ5bXFF?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T15:23:38+00:00", "published_display": "09 Jul 2026 15:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Stock Gains 43.7% in 2026: What's Powering the Rally?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNUlpXUVo1TjFSQjVQblBkc3FBNmYxVENkTlM1aXhjbE55U2V0TW9tcGMxSWpySmhVZzloT0JJNS1McEI2eWZlbzNJY1BLVGRGMmpwWlc0LXBXbFdFYU1sdmE2NWhOSC11YmpaNlBubzlhajZIVlNuWXFFMWRzX2ZjYXdWcGhieFg0WGhTSFFoV2hJWDc4?oc=5", "source_name": "Market source", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Inc. stock outperforms competitors despite losses on the day", "summary": "Illumina Inc. (ILMN) shares fell 2.06% to $187.81, marking its second consecutive day of losses. Despite this decline, the stock still outperformed the broader market, as the S&P 500 Index and Dow Jones Industrial Average also experienced losses on the day.", "url": "https://www.marketwatch.com/data-news/illumina-inc-stock-outperforms-competitors-despite-losses-on-the-day-fad95205-3db23d5e6eaa?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-08T17:21:00", "published_display": "08 Jul 2026 17:21", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Beat Expectations, Is The Stock Fully Priced?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T13:30:40+00:00", "published_display": "08 Jul 2026 13:30", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue?", "summary": "Illumina (ILMN) shares recently hit a 52-week high, surging 19.8% in the past month and 46.2% year-to-date, outperforming the Zacks Medical sector. The company has consistently beaten earnings estimates, with expected EPS growth. While its valuation metrics are higher than indust", "url": "https://sg.finance.yahoo.com/news/illumina-inc-ilmn-hit-52-131505376.html", "source_name": "Market source", "published_at": "2026-07-08T13:39:57", "published_display": "08 Jul 2026 13:39", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Stock May Be 27% Undervalued Following Strong Q1 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOQ25ZS1hIYVRxS0hneW9waXp1dmFVaF91TU1EczdQRVpKLUhyQURsTmgyMGpYQVM1Yi1uQTJmakdjUTlFMjVZcGlrWGRzaFJuZ1pJcUZ6eVpqbXI2NVMtc2xQaVVmdUZTeUFzSzdtODdyQmdGOS1STE9oSW1Hd2VDVHZ2ZG91NjJRN3RRUW9vMkhHWmpvSlE?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Jumps On Earnings And Guidance As Valuation Questions Remain", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPWndFZGlpZG9pVk0wNnh4U25RcDFDOGYwTlZTYUJTeFFSaEVqQk45X3JNLVNpQnJGT1ZvQUxLUEViT1JsTHZQQl8tOGw3Y210LVRCMzJuSzRMYXd6TVZ3SjRCNVdsYkFwd3Z4dFlJVGhtSlpxN3N0bllRSUZITXN4U2h0VW5odVVJVGZ0OFRhNTBCRHBjWWFMaWF0UDJxdFkxVno0TA?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Inc. stock underperforms Tuesday when compared to competitors", "summary": "Shares of Illumina Inc. (ILMN) fell 1.32% on Tuesday, closing at $191.76, amidst a general market downturn where the S&P 500 Index and Dow Jones Industrial Average also declined. This dip ended a three-day winning streak for Illumina's stock. The article highlights Illumina's und", "url": "https://www.marketwatch.com/data-news/illumina-inc-stock-underperforms-tuesday-when-compared-to-competitors-6a664f94-acaaf068018b", "source_name": "MarketWatch", "published_at": "2026-07-07T17:22:00", "published_display": "07 Jul 2026 17:22", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Illumina (ILMN) Quietly Recasting Its Clinical Genomics Strategy With Eli Lilly\u2019s R&D Chief on Board?", "summary": "Illumina recently appointed Daniel M. Skovronsky, Eli Lilly\u2019s Chief Scientific and Product Officer, to its board, potentially influencing its clinical genomics and next-generation sequencing strategy. This move aligns with Illumina's focus on clinical applications like minimal re", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ilmn/illumina/news/is-illumina-ilmn-quietly-recasting-its-clinical-genomics-str", "source_name": "Simply Wall Street", "published_at": "2026-07-06T03:39:49", "published_display": "06 Jul 2026 03:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(ILMN) Risk Channels and Responsive Allocation", "summary": "This article analyzes Illumina Inc. (ILMN), indicating a strong overweight bias across all time horizons based on AI models. It highlights the absence of resistance levels above the current price, suggesting significant upside potential. Three distinct trading strategies are pres", "url": "https://news.stocktradersdaily.com/news_release/149/ILMN_Risk_Channels_and_Responsive_Allocation_070526034001_1783237201.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-05T03:11:04", "published_display": "05 Jul 2026 03:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Continue to Hold ILMN Stock in Your Portfolio?", "summary": "Illumina Inc. (ILMN) is poised for growth due to its focus on core sequencing, multiomics expansion, and strong NovaSeq X placements, despite challenges in the China market and macroeconomic pressures. The company surpassed Q1 2026 estimates, raised full-year guidance, and sees c", "url": "https://www.tradingview.com/news/zacks:07e37f738094b:0-should-you-continue-to-hold-ilmn-stock-in-your-portfolio/", "source_name": "TradingView", "published_at": "2026-07-03T12:39:26", "published_display": "03 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 69, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Illumina, Inc. \u2013 NASDAQ:ILMN", "summary": "This article provides access to the \"Price to sales forward\" metric for Illumina, Inc. (NASDAQ: ILMN) on the TradingView platform. It is a financial data point for the health technology company. The content appears to be a truncated view of a financial data page rather than a det", "url": "https://www.tradingview.com/symbols/NASDAQ-ILMN/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T02:39:26", "published_display": "03 Jul 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Illumina Inc For: 2 July By Investing.com", "summary": "This article reports on a Form 4 filing for Illumina Inc. dated July 2nd. It notes a 2.60% increase in ILMN stock and provides an overview of various financial market data including indices, commodities, bonds, and trending stocks. The content is presented by Investing.com, a fin", "url": "https://ca.investing.com/news/stock-market-news/form-4-illumina-inc-for-2-july-93CH-4719308", "source_name": "Investing.com Canada", "published_at": "2026-07-02T22:14:18", "published_display": "02 Jul 2026 22:14", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] ILLUMINA, INC. Insider Trading Activity", "summary": "ILLUMINA, INC. director Scott B. Ullem reported an acquisition of 167 shares of common stock on June 30, 2026, as compensation for his second-quarter board and committee retainer fees. The shares, valued at $149.1868 each, were granted based on the volume-weighted average closing", "url": "https://www.stocktitan.net/sec-filings/ILMN/form-4-illumina-inc-insider-trading-activity-666474e93acd.html", "source_name": "Stock Titan", "published_at": "2026-07-02T22:14:18", "published_display": "02 Jul 2026 22:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) director takes 2026 board fees entirely in stock", "summary": "Illumina director Keith A. Meister has opted to receive 100% of his 2026 board and committee cash retainer fees in company stock. For the second quarter of 2026, this resulted in a grant of 142 shares at a reference price of $149.1868 per share, increasing his direct holdings to ", "url": "https://www.stocktitan.net/sec-filings/ILMN/form-4-illumina-inc-insider-trading-activity-c27ed0ac395f.html", "source_name": "Stock Titan", "published_at": "2026-07-02T22:14:18", "published_display": "02 Jul 2026 22:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ILMN - Illumina Inc Volatility & Greeks", "summary": "This article provides a detailed snapshot of Illumina Inc. (ILMN) financial and stock performance data as of July 2, 2026. It includes key metrics such as market capitalization, income, sales, various P/E ratios, EPS growth rates, insider and institutional ownership, profitabilit", "url": "https://finviz.com/stock?t=ILMN&ty=ocv&ta=1&p=w&ov=chain_date&e=2028-01-21", "source_name": "Finviz", "published_at": "2026-07-02T18:39:26", "published_display": "02 Jul 2026 18:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Gets Bernstein\u2019s Market Perform Rating Amid NovaSeq X Recovery", "summary": "Bernstein SocGen analyst Eve Burstein has resumed coverage of Illumina (NASDAQ: ILMN) with a Market Perform rating and a $185 price target, citing the company's recovery from a difficult period. Illumina faced challenges in early 2025 due to China restricting imports of its seque", "url": "https://www.insidermonkey.com/blog/illumina-ilmn-gets-bernsteins-market-perform-rating-amid-novaseq-x-recovery-1793109/", "source_name": "Insider Monkey", "published_at": "2026-07-01T17:30:00", "published_display": "01 Jul 2026 17:30", "sentiment": "positive", "sentiment_pct": 60, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piper Sandler raises Illumina stock price target on clinical strength", "summary": "Piper Sandler increased its price target for Illumina (NASDAQ:ILMN) to $200 from $170, maintaining an Overweight rating, based on the company's strong clinical business momentum and dominance in the genomics market. The firm highlighted Illumina's NovaSeq X system, which accounts", "url": "https://www.investing.com/news/analyst-ratings/piper-sandler-raises-illumina-stock-price-target-on-clinical-strength-93CH-4770660", "source_name": "Investing.com", "published_at": "2026-07-01T13:29:31", "published_display": "01 Jul 2026 13:29", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche takes on Illumina with new NGS system", "summary": "Roche is entering the next-generation sequencing market with its new Axelios 1 system, directly challenging Illumina's long-standing dominance. The Axelios 1 platform utilizes a novel \"sequencing by expansion\" (SBX) technology, which Roche claims offers improved accuracy, scalabi", "url": "https://www.medtechdive.com/news/roche-takes-on-illumina-with-new-ngs-system/824146/", "source_name": "MedTech Dive", "published_at": "2026-06-30T20:40:31", "published_display": "30 Jun 2026 20:40", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Illumina, Inc. \u2013 TURQUOISE:ILMNN", "summary": "This article displays the \"Price to earnings forward\" value for Illumina, Inc. (ILMNN) on the Turquoise market. It indicates that the market is currently closed with no trades. The data is provided by ICE Data Services and FactSet Research Systems Inc.", "url": "https://www.tradingview.com/symbols/TURQUOISE-ILMNN/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T10:41:49", "published_display": "29 Jun 2026 10:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche takes aim at Illumina's dominance with new gene sequencing machine", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNMUZtcHk0a3pVMUJ2akdyXzBZYk9waEdtN21IaHRKLUN0S1FsbVcxN21qb2hadFBQcnp5OHQ1MlRnekhYYXVoY3hza1NWWnpzdG40V3RaUDI3WVdiNnBfejl5SGxhel96blhXLURyeW9mbnpTWGNiX0RDZ1RITE94SlQ5cnlCVE1uaHIxWVFCX2VIWUxvZVdrTnVNbHczZEQ3WXNmSlZfcmZwRHVyS0l1X0Q0OXpzMEE?oc=5", "source_name": "Reuters", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche Launches AXELIOS 1 Sequencer At $750,000, Targeting Illumina\u2019s Market", "summary": "Roche has launched its new AXELIOS 1 Sequencer, priced at $750,000, directly challenging Illumina's market dominance. The sequencer is capable of generating reads up to 1,500 base pairs, positioning Roche as a significant competitor in the genomics sequencing industry. This move ", "url": "https://insights.citeline.com/medtech-insight/business/strategy/roche-launches-axelios-1-sequencer-at-750000-targeting-illuminas-market-NRUE7DGMUNEWDPFKW4R3EKPOWA/", "source_name": "insights.citeline.com", "published_at": "2026-06-29T07:13:23", "published_display": "29 Jun 2026 07:13", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh Actuals & Estimates (BMFBOVESPA:I1LM34)", "summary": "This page provides financial actuals and estimates for Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh (BMFBOVESPA:I1LM34) on TradingView. Users can explore reported financial data and analyst estimates, comparing actual results with average, high, and low est", "url": "https://www.tradingview.com/symbols/BMFBOVESPA-I1LM34/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-26T16:10:29", "published_display": "26 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Stock Is Up 32% in 2026: Has the GRAIL Recovery Already Been Priced In?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNWlpjN2RyeExiOHl1aDNkaUhZeHpvQXFPNWRJX1Y2Ukd3eVUwdTBUWExXcWhaR1dCMnBYSXhNem51bVl3dHUzazllU3VHU0ljYVZ5V2RfamNHMTF3dWN6N1NDNGYtOG45RkwwUTdldUd3STY3SThEWVE2SmZPREZtdGF6Wi1seThacXdnNHNJN3dsZWdJcnhocm1XTFN6MlA4UEpjUVFB?oc=5", "source_name": "TIKR.com", "published_at": "2026-06-26T13:30:56+00:00", "published_display": "26 Jun 2026 13:30", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Scott Davies Sells Shares of Illumina Inc (ILMN)", "summary": "Scott Davies, Chief Legal Officer of Illumina Inc's subsidiary, sold 615 shares of Illumina Inc (ILMN) on June 25, 2026. This transaction brings his total holdings to 20,953 shares. The stock is currently trading at $180, significantly above its GF Value of $129.16, indicating it", "url": "https://www.gurufocus.com/news/8932905/insider-sell-scott-davies-sells-shares-of-illumina-inc-ilmn", "source_name": "GuruFocus", "published_at": "2026-06-26T04:10:08", "published_display": "26 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (NASDAQ: ILMN) legal chief sells 615 shares in open-market trade", "summary": "Illumina's Chief Legal Officer, Scott M. Davies, sold 615 shares of the company's common stock at $180 per share in an open-market transaction. This sale, totaling $110,700, represents a small portion of his overall direct holdings, which now stand at 20,953 shares. The transacti", "url": "https://www.stocktitan.net/sec-filings/ILMN/form-4-illumina-inc-insider-trading-activity-6d04287d37fb.html", "source_name": "Stock Titan", "published_at": "2026-06-26T02:10:08", "published_display": "26 Jun 2026 02:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (NASDAQ: ILMN) affiliate files Form 144 reporting 98,400-share 10b5-1 sale", "summary": "An Illumina (NASDAQ: ILMN) affiliate has filed Form 144 to report the proposed sale of 98,400 common shares. The filing details a 10b5-1 sale on May 29, 2026, linked to Performance Stock Units and Restricted Stock Units granted on February 21, 2023. This is a regulatory notice of", "url": "https://www.stocktitan.net/sec-filings/ILMN/144-illumina-inc-sec-filing-08050a9ce2c4.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:09:45", "published_display": "25 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Frances Arnold sells Illumina shares (ILMN) in multiple May\u2013June 2026 trades", "summary": "Frances Arnold reported proposed sales of Illumina (ILMN) common stock through a Form 144 filing, detailing multiple dispositions in May\u2013June 2026. These include sales of 3,000 shares on June 2, 2026, for $484,571.70 and 5,000 shares on May 28, 2026, for $780,650.00. The filing a", "url": "https://www.stocktitan.net/sec-filings/ILMN/144-illumina-inc-sec-filing-8939223f29e6.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:09:45", "published_display": "25 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Jumps 7.7% Amid Sector-Wide Rally", "summary": "Illumina (ILMN) saw its stock surge by 7.7% on Wednesday, closing at $177.66, driven by a broad sector-wide rally in diagnostics and research stocks. This gain was part of a larger trend, with several other life sciences companies also experiencing significant increases. The rall", "url": "https://news.alphastreet.com/illumina-jumps-7-7-amid-sector-wide-rally/", "source_name": "AlphaStreet", "published_at": "2026-06-25T11:10:08", "published_display": "25 Jun 2026 11:10", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) director Daniel Skovronsky receives 1,674-share RSU grant", "summary": "Illumina director Daniel Skovronsky received a grant of 1,674 restricted stock units (RSUs), valued at $164.28 per share, representing his total direct holding after this transaction. The RSUs will vest entirely on the earlier of one year from the grant date or the date immediate", "url": "https://www.stocktitan.net/sec-filings/ILMN/form-4-illumina-inc-insider-trading-activity-57fe56c1ae9e.html", "source_name": "Stock Titan", "published_at": "2026-06-24T22:10:50", "published_display": "24 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Illumina (ILMN) Stock Is Trading Up Today", "summary": "Illumina's stock (ILMN) surged 6.6% after the company appointed Daniel M. Skovronsky, a high-profile Eli Lilly executive, to its board of directors. Barclays also increased its price target for Illumina to $145 from $122, noting that life science and diagnostic tools are gaining ", "url": "https://uk.finance.yahoo.com/news/why-illumina-ilmn-stock-trading-185625423.html", "source_name": "Market source", "published_at": "2026-06-24T18:40:05", "published_display": "24 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Stock After 80% One-Year Rebound Is The Price Now Justified", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPbEM5TV9ld2cxRjhFOWxwcVBWbXZYU3NjaFBtak8zUEl2ck40dHhrU3ptV1h0OHlVZXE4TjQ2Z20waC1jN1ZyQ0t1Rl9DWVFzTVQwa0lrcDZDREtWUFFuV3M2dnFGOGdHSDRrUW1LSXJPaDNDcVdwLS03aFMzeEVoZ0REanFMMGNraGJiLXFJa291dll2bEE?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQNWc4cG9KbU1YZ1RhMjQ3bzB0eEpvS2ZkbE5xN1NYdDhuSmlzbXVTZGlUdWxneEU4ekFuelBFX1I3Vng2cmFINU92S1VsTlJCRk5mc1J6UmFOQkV3RmVrNG1tNGR2WFlTZTNZRlQxQm9DUWxRSGI4bzNIOHZ6eGVacmRuZHp0WTVJeHJzS2ZDU2hfanA3cUdtY1lGZmJLNVZXcUNaVHlBQktLSzIwRm8zM2xVRFRrOWNJWmRNekU1RHVXUQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Stock After 88% Rebound Is The Current Price Still Attractive", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Stock\u2019s Operating Margin Climbs to 22% in Q1 2026: Is it Enough to Support a $300 Target?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNc1E1aWRuQTFQN2FSNk91Y2w2Q1hEcy1iN3dCSXNTTjdnNlg0ZXhHdlJTSmpTeVcxNDU0LW50ZURFQnFkUnVLMkVDZFItOFg0ekUtSVJLNnRsNWo5YUVLcnN6M2FZRHB0SHl2U2VDWnlVb1hFMUE0M2hnVEQtRVJ6N3Jva3N4Szc5LThIeE9yWTZZbFlpbUxLcU92Z0Y4bXVSSzhrb3NsZEZNbmJsUTEtaEdrRHRhcUsxd25Z?oc=5", "source_name": "TIKR.com", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Inc. stock (US4523271090): shares track Nasdaq ahead of next catalysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQnpGaWt3Wm02b3VqNlBpYkR1N2NUd2FJa2RfN2JDWXN4VG1DakRidVYtSkphcU5qQUlxZUZVejFDVmthaUhZd3E2Y2h6dUtCTFE5OXRPMFZTU1NPVElfdFpVZExZYm9rSGdwT3RXbzVWWW10XzhKcHo5R2dxeWYtN1FheHQydGEydVR0MjdNNlV0TmFFWktncExSb1E2ZHJHeDZJa0tVZHcwbzhGV29VQUhmTy1HeTVIMC1xSl9OMmdjQQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Inc stock (US4523271090): New MRD research launch and fresh 52-week high draw focus to valu", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNR2hUa1RZa1V4b0Q3RllaRDRzcUlqaHhqSENIeER2ZUxmRThmd0lyMnpnYjRRYlNDOXc4SHlyLWo3TmhKcWZsYmdDOGlZU1l0R2xBNnVoWVFLNEh2cmI1RU5hcXNTcGxIdmQwb1ZYTWYySUFIa2d1WndBbmJDTE1ORnhHNFhTbk51amwxSUlKVWEyZ0NZUjMzdnRkaURyRUVWQTJ1SmM2Zy1kenczR2dmeUprdFVPaDZNUEZHMzNsVWNaUQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Inc. stock (US4523271090): shares near 12-month high after new automation launch", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNRDN1VkJJVGt5clo4bWtsQUpWc1c0d0hfSDk4YU9lc0stdWJHZUExNERRYTlYRVBzVnNia1NUQTlvS0FENElwdWFuVTFSaGNyMzJJeXc0RDVKZHEtSTRqZlNlNm0xdW9CYVExUFY3NVFJTFd1Zm5nTjgydFNOOTl2QXJCRHRwczZlTkZELTRVY05RaEE2ZUhNNWxFN01uckdzSUl6QzVfRGRXdXJxOUttU2hhNnNrWG43bU04WnljTGVVeF95?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina stock (US4523271090): analysts see limited upside after volatile Nasdaq recovery", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOUTJhNGJRblhaMlNmWGVzRWRKX0Yxbzc0eld4UHBpOTUzamRMcDFjbzVWLS1keEhzT2c3LXlWR2lBYmpQbi1wMXdmZlYtR1lIdDQ0S1N4QjFyNnlVcElWSTJsSm1nT3dOdkZJWFB2Sm92YWh1MG1WM29QYmNjdFpxZFFNZWIwN1o5ajBOekRpMURMb3ktVmpISDRjUEZ1cmpoWnM5eTJHZFpyWmkxaEM1TEh5dTFadWNZc3NIRUZ5Wmtaem12SGZ5eg?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina stock (US4523271090): gene sequencing player in focus after leadership and strategy updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSXNzem5fVjdnb3FrQ3lOOVJoNXpDbDNvbFVMdXVlbC0zZEtxR0xEOGo2Y21ISDRyaVBid001MC1lY2ZZQjdwTlJ5bl9RU0VUQ1BSR3N0NjhqQzVRVlFHb3BiREhlVW1jUUZsWnVkeHJpNGF4V0t5N2tDdUpDWmZJRHRWRWhTM2pDM2lWd1V0bTNfMGk2anFhVDdiSlROWU15ZVNYMzdubHNLYUVVaVUyNUN6dzllRFg1bWNXTHFtUS15dw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina stock (US4523271090): Q1 2026 earnings beat signals recovery momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPclAxU285cW9TTWNyeDI1b2owR0M2ZVhXdkRRSkdQQk56WTdKczl5aEpxcEF2X0lPN3VWSFNMcDNNX29IMjVYX3VyLVl4SEhEbHVkdUY3SDcwSHdxYmJDR0ZydHNuQWlfNGUtYnFmcDFjU1RnS1B4cGZ4WHpOVHJ5a1RfUUExQWgtSFRLSzZ5TXdRNVY1ck1LWDJERU5ydDRDNWJrOGNMby1Zb1hrbWw5WkVuQVoxbG95azd0a0pRRFhGXzg?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Form 144 lists 600,000 shares with Goldman Sachs broker", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQYTJpWEZvZWc2WVBzc1g1NFp3X1J0d1dRN3hqSi1NOTBPSHFhSklIaWE3T2NjTlkzcTlWak81R2xHbERrc1pzMWVuSlFNbGdLSm43dFBvSGd6SGZrUk5KS2hGb2Y3eWxxU09MTEl1UjFscU1mTEs5R0c5QUljbEpIenNYYUdaTlFRLV9UQ1JXazk1eTQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think That There Are Issues Underlying Illumina's (NASDAQ:ILMN) Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) One Off Gain Shapes Profitability Narrative Heading Into 2026 Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxObkN4SU95UDlrSWJvMkNGd2RoS1QwRGFMeUNoMHVxcFdCOWpSaWVEMmJ1YURra1hhcWlwSmZHT0Zpbjl3Y3RMX1FWbEhiM3VRdWtwSG1Xc1BWTURCejdlblZoS3ZCLTM4YXZ2Wl9QdTdkRF9SUDRqeUIteUNuVUVfcEVwc0RXR05lMnZBdVNURFd3MXFxc2xWSktEeFdxc0ctd1lfMTh3RmFHNzh0VmVmZmh3T2lhQUsxWGc?oc=5", "source_name": "TradingView", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Reports Financial Results for First Quarter of Fiscal Year 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOU29DWmY2MVliX294RVhkQjAwUmJWZW9Sa29MY0J6cngzN2Rod1FGRlNoN2h1NlNUNXROdkVjVDZxYVNYSXcyZjlKSFo0ZTEwZ1BveFQwRTFZR1BSb0MzSkdNa3lsd0Q5VzBnaEZmMG9MT3dfdDQxNExyZUFEeWxpVUI1eWtZUlctTjA2YzN0UnNkUy1TT19SWmtBSTlPazg2a19nQnV6M0gtcjlXUlRQUGN4Uy0yd3NzT2ZkU19SamM1enpmTDlR?oc=5", "source_name": "PR Newswire", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Stock Climbs 44.8% in a Year: What's Driving the Rally?", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5ZMDIzVmhYVEp3eHVOOFVIaFR0WmZEYU93Wlo3SEV4R09FUU9TRE93OHRJemdyVXg1dDczUGZvYU0zelZUbTZFTWVjLUdmTkNPTzlZUk9lLTROM3VMSlZzWkZlNndaTnNRUk9vRm9VRVB4cFNZTVNzd0s3Umw?oc=5", "source_name": "Market source", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GRAIL Inc. - Illumina's Divested Holy Grail (NASDAQ:GRAL)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNNHRZMFVDVlFhMTJrN0xoYlloN3pxdjItLWY0Q0s0N2ZwUHRxRkQwc0t5WGx4dmljWHpHdmQzQnFKYWt6aWFXRDkyRFhjOFczdkdTeWNoLXZkcUVQbTFxMlVJRGRKNTRYdU93YkttWFd5V3VabHRseEV0YmtNUUhIakhYa2V6QTg?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-20T08:00:00+00:00", "published_display": "20 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina, Inc. (NASDAQ:ILMN) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-09T08:00:00+00:00", "published_display": "09 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQdWE5RW5idmo0UjFRYnNjMDR4RTNLOFFwNVE5cTZsNTlyTW8xTUVDdU9nQVZkOE4zdm43b1FXYVUxR2hlUEMtZlRCZWh3WTFKWGpXS0syenktbDRyNlZiLUNLREVlMGpHZFppNzNZVzA2WXZURWZ6cXVhOFNzX0xqZUhxaVE2VjYyNkh1WFVtWjcyVldXcFNNdXZIaWlIOUFkZVRWbWV5N2lvUENGcUpjdzVmWTUzd3RIMWdsLV9JbGdPeDhQS0Y2TA?oc=5", "source_name": "PR Newswire", "published_at": "2025-07-31T07:00:00+00:00", "published_display": "31 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Is Illumina Inc (ILMN) Overvalued After 4.2% Rally? GF Value Say", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOSTFyN0VyUndBR0lFTVVHVnlSUnRvVGVPeTVQcnZDV2d3T0VRSlhSOVFrWVI1TEhwVnVmTGhOZjhwYzhLSUIweE1uUzA3Vk5QcE01N184d29Hc2ZDOEtUR3VKTGVQX0FQZkdxU3ZsZUdCY0JNaGJ2aDV6ekp0NHoybm9oM1BYeV9UbGU5RWxWNWtYYm1mTmVlMlo1Qm4xR3hMSGxRdUQ5cjJyd3JHS3F3?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-21T22:32:24+00:00", "published_display": "21 Jul 2026 22:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lobbying Update: $300,000 of ILLUMINA INC. lobbying was just disclosed", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQc0V4bDFETERJcTlkV3hBQ1RJRnU0bHppU2FSS1RBQURIaDRJMFV5cWFiZVhrLVl6eUxDMF80SGx4QkhYbmI2NXcxWGJTRGU2MmMtVUFXVExDcDZyWmdjcG1zWENacy0xNXZseV9fenFMT1pqQWIySG1iM09sX0hGMHVXMDBLU3JSNkM1c1JHa0tyNkNGRmFnTEp0NEcxN095QnBvOF82UjFuVWlzLWc?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-21T17:55:00+00:00", "published_display": "21 Jul 2026 17:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eli Lilly (LLY) Joins Illumina Atlas To Map Disease With AI", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/eli-lilly-lly-joins-illumina-221235419.html", "source_name": "Simply Wall St.", "published_at": "2026-07-20T22:12:35+00:00", "published_display": "20 Jul 2026 22:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Faces German Recall Order Over Element Sequencing Patent Ruling", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/illumina-ilmn-faces-german-recall-231748469.html", "source_name": "Simply Wall St.", "published_at": "2026-07-16T23:17:48+00:00", "published_display": "16 Jul 2026 23:17", "sentiment": "negative", "sentiment_pct": 42, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina expands Billion Cell Atlas program with new AI drug developers", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/illumina-expands-billion-cell-atlas-160000451.html", "source_name": "PR Newswire", "published_at": "2026-07-16T16:00:00+00:00", "published_display": "16 Jul 2026 16:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Juno Bio Opens First CLIA-Certified Sequencing Lab Dedicated Entirely to Women's Health, Backed by Ada Ventures, Artesian, Illumina Accelerator, and Entrepreneur First", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/juno-bio-opens-first-clia-131400815.html", "source_name": "PR Newswire", "published_at": "2026-07-16T13:14:00+00:00", "published_display": "16 Jul 2026 13:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Illumina (ILMN) Stock Is Down Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPQjlyMzE3bmxlVW9QWFltXzRya25faHFVaE1qS1Bma3hYSkFDS3VkRi10MURSQVdsSWMzSUVzQU9YbGpIanQzQmgzRURNMEU3VUpFZHJFRnZkeUtmVmJRdTExMmlnMzQ4VldIQzVKZzZjVFd1NWJ1dXp0V1dnemtzenpjUWtuZw?oc=5", "source_name": "Moomoo", "published_at": "2026-07-15T18:36:31+00:00", "published_display": "15 Jul 2026 18:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Element Biosciences Prevails in German Patent Case Against Illumina", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/element-biosciences-prevails-german-patent-120000561.html", "source_name": "Business Wire", "published_at": "2026-07-14T12:00:00+00:00", "published_display": "14 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Inc. stock outperforms competitors on strong trading day", "summary": "Illumina Inc. (ILMN) stock increased by 3.17% to $193.76, outperforming the broader market during a positive trading session. This rise ended a two-day losing streak for the company's shares. The S&P 500 Index and Dow Jones Industrial Average also saw gains, rising 0.81% and 0.27", "url": "https://www.marketwatch.com/data-news/illumina-inc-stock-outperforms-competitors-on-strong-trading-day-8dde6293-118f7d902bf2", "source_name": "MarketWatch", "published_at": "2026-07-09T17:22:00", "published_display": "09 Jul 2026 17:22", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina stock steadies as investors weigh core sequencing demand and regulatory overhang", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQazRaMWdDUXFGc3VYd0sxZXJGMHhSWkY2eWFhX2xabFl4WGlieHBwZzNpUXdjOEZraWNSeFBqdWJvSDJ2Yy1LOVQ5Q2NsV1FSYno5NGtQeEduMGl3dUJ2MWZMcmZ2WDlMWHBHb2RCamtGZEQwazBIUkdFbXU0WGV0WGhJeG9hVWl3ZEhhSWZQN3dOSFVkcktWeG9mMXJVWGpSc0J2M1NoZEg0VFNrSnFyRWptUnFzSFVxOUFYNktWOXk1MWJ5bXFF?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T15:23:38+00:00", "published_display": "09 Jul 2026 15:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Stock Gains 43.7% in 2026: What's Powering the Rally?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNUlpXUVo1TjFSQjVQblBkc3FBNmYxVENkTlM1aXhjbE55U2V0TW9tcGMxSWpySmhVZzloT0JJNS1McEI2eWZlbzNJY1BLVGRGMmpwWlc0LXBXbFdFYU1sdmE2NWhOSC11YmpaNlBubzlhajZIVlNuWXFFMWRzX2ZjYXdWcGhieFg0WGhTSFFoV2hJWDc4?oc=5", "source_name": "Market source", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Inc. stock outperforms competitors despite losses on the day", "summary": "Illumina Inc. (ILMN) shares fell 2.06% to $187.81, marking its second consecutive day of losses. Despite this decline, the stock still outperformed the broader market, as the S&P 500 Index and Dow Jones Industrial Average also experienced losses on the day.", "url": "https://www.marketwatch.com/data-news/illumina-inc-stock-outperforms-competitors-despite-losses-on-the-day-fad95205-3db23d5e6eaa?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-08T17:21:00", "published_display": "08 Jul 2026 17:21", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Beat Expectations, Is The Stock Fully Priced?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T13:30:40+00:00", "published_display": "08 Jul 2026 13:30", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue?", "summary": "Illumina (ILMN) shares recently hit a 52-week high, surging 19.8% in the past month and 46.2% year-to-date, outperforming the Zacks Medical sector. The company has consistently beaten earnings estimates, with expected EPS growth. While its valuation metrics are higher than indust", "url": "https://sg.finance.yahoo.com/news/illumina-inc-ilmn-hit-52-131505376.html", "source_name": "Market source", "published_at": "2026-07-08T13:39:57", "published_display": "08 Jul 2026 13:39", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Stock May Be 27% Undervalued Following Strong Q1 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOQ25ZS1hIYVRxS0hneW9waXp1dmFVaF91TU1EczdQRVpKLUhyQURsTmgyMGpYQVM1Yi1uQTJmakdjUTlFMjVZcGlrWGRzaFJuZ1pJcUZ6eVpqbXI2NVMtc2xQaVVmdUZTeUFzSzdtODdyQmdGOS1STE9oSW1Hd2VDVHZ2ZG91NjJRN3RRUW9vMkhHWmpvSlE?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Jumps On Earnings And Guidance As Valuation Questions Remain", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPWndFZGlpZG9pVk0wNnh4U25RcDFDOGYwTlZTYUJTeFFSaEVqQk45X3JNLVNpQnJGT1ZvQUxLUEViT1JsTHZQQl8tOGw3Y210LVRCMzJuSzRMYXd6TVZ3SjRCNVdsYkFwd3Z4dFlJVGhtSlpxN3N0bllRSUZITXN4U2h0VW5odVVJVGZ0OFRhNTBCRHBjWWFMaWF0UDJxdFkxVno0TA?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Inc. stock underperforms Tuesday when compared to competitors", "summary": "Shares of Illumina Inc. (ILMN) fell 1.32% on Tuesday, closing at $191.76, amidst a general market downturn where the S&P 500 Index and Dow Jones Industrial Average also declined. This dip ended a three-day winning streak for Illumina's stock. The article highlights Illumina's und", "url": "https://www.marketwatch.com/data-news/illumina-inc-stock-underperforms-tuesday-when-compared-to-competitors-6a664f94-acaaf068018b", "source_name": "MarketWatch", "published_at": "2026-07-07T17:22:00", "published_display": "07 Jul 2026 17:22", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Illumina (ILMN) Quietly Recasting Its Clinical Genomics Strategy With Eli Lilly\u2019s R&D Chief on Board?", "summary": "Illumina recently appointed Daniel M. Skovronsky, Eli Lilly\u2019s Chief Scientific and Product Officer, to its board, potentially influencing its clinical genomics and next-generation sequencing strategy. This move aligns with Illumina's focus on clinical applications like minimal re", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ilmn/illumina/news/is-illumina-ilmn-quietly-recasting-its-clinical-genomics-str", "source_name": "Simply Wall Street", "published_at": "2026-07-06T03:39:49", "published_display": "06 Jul 2026 03:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(ILMN) Risk Channels and Responsive Allocation", "summary": "This article analyzes Illumina Inc. (ILMN), indicating a strong overweight bias across all time horizons based on AI models. It highlights the absence of resistance levels above the current price, suggesting significant upside potential. Three distinct trading strategies are pres", "url": "https://news.stocktradersdaily.com/news_release/149/ILMN_Risk_Channels_and_Responsive_Allocation_070526034001_1783237201.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-05T03:11:04", "published_display": "05 Jul 2026 03:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Continue to Hold ILMN Stock in Your Portfolio?", "summary": "Illumina Inc. (ILMN) is poised for growth due to its focus on core sequencing, multiomics expansion, and strong NovaSeq X placements, despite challenges in the China market and macroeconomic pressures. The company surpassed Q1 2026 estimates, raised full-year guidance, and sees c", "url": "https://www.tradingview.com/news/zacks:07e37f738094b:0-should-you-continue-to-hold-ilmn-stock-in-your-portfolio/", "source_name": "TradingView", "published_at": "2026-07-03T12:39:26", "published_display": "03 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 69, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Illumina, Inc. \u2013 NASDAQ:ILMN", "summary": "This article provides access to the \"Price to sales forward\" metric for Illumina, Inc. (NASDAQ: ILMN) on the TradingView platform. It is a financial data point for the health technology company. The content appears to be a truncated view of a financial data page rather than a det", "url": "https://www.tradingview.com/symbols/NASDAQ-ILMN/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T02:39:26", "published_display": "03 Jul 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Illumina Inc For: 2 July By Investing.com", "summary": "This article reports on a Form 4 filing for Illumina Inc. dated July 2nd. It notes a 2.60% increase in ILMN stock and provides an overview of various financial market data including indices, commodities, bonds, and trending stocks. The content is presented by Investing.com, a fin", "url": "https://ca.investing.com/news/stock-market-news/form-4-illumina-inc-for-2-july-93CH-4719308", "source_name": "Investing.com Canada", "published_at": "2026-07-02T22:14:18", "published_display": "02 Jul 2026 22:14", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] ILLUMINA, INC. Insider Trading Activity", "summary": "ILLUMINA, INC. director Scott B. Ullem reported an acquisition of 167 shares of common stock on June 30, 2026, as compensation for his second-quarter board and committee retainer fees. The shares, valued at $149.1868 each, were granted based on the volume-weighted average closing", "url": "https://www.stocktitan.net/sec-filings/ILMN/form-4-illumina-inc-insider-trading-activity-666474e93acd.html", "source_name": "Stock Titan", "published_at": "2026-07-02T22:14:18", "published_display": "02 Jul 2026 22:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) director takes 2026 board fees entirely in stock", "summary": "Illumina director Keith A. Meister has opted to receive 100% of his 2026 board and committee cash retainer fees in company stock. For the second quarter of 2026, this resulted in a grant of 142 shares at a reference price of $149.1868 per share, increasing his direct holdings to ", "url": "https://www.stocktitan.net/sec-filings/ILMN/form-4-illumina-inc-insider-trading-activity-c27ed0ac395f.html", "source_name": "Stock Titan", "published_at": "2026-07-02T22:14:18", "published_display": "02 Jul 2026 22:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ILMN - Illumina Inc Volatility & Greeks", "summary": "This article provides a detailed snapshot of Illumina Inc. (ILMN) financial and stock performance data as of July 2, 2026. It includes key metrics such as market capitalization, income, sales, various P/E ratios, EPS growth rates, insider and institutional ownership, profitabilit", "url": "https://finviz.com/stock?t=ILMN&ty=ocv&ta=1&p=w&ov=chain_date&e=2028-01-21", "source_name": "Finviz", "published_at": "2026-07-02T18:39:26", "published_display": "02 Jul 2026 18:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Gets Bernstein\u2019s Market Perform Rating Amid NovaSeq X Recovery", "summary": "Bernstein SocGen analyst Eve Burstein has resumed coverage of Illumina (NASDAQ: ILMN) with a Market Perform rating and a $185 price target, citing the company's recovery from a difficult period. Illumina faced challenges in early 2025 due to China restricting imports of its seque", "url": "https://www.insidermonkey.com/blog/illumina-ilmn-gets-bernsteins-market-perform-rating-amid-novaseq-x-recovery-1793109/", "source_name": "Insider Monkey", "published_at": "2026-07-01T17:30:00", "published_display": "01 Jul 2026 17:30", "sentiment": "positive", "sentiment_pct": 60, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piper Sandler raises Illumina stock price target on clinical strength", "summary": "Piper Sandler increased its price target for Illumina (NASDAQ:ILMN) to $200 from $170, maintaining an Overweight rating, based on the company's strong clinical business momentum and dominance in the genomics market. The firm highlighted Illumina's NovaSeq X system, which accounts", "url": "https://www.investing.com/news/analyst-ratings/piper-sandler-raises-illumina-stock-price-target-on-clinical-strength-93CH-4770660", "source_name": "Investing.com", "published_at": "2026-07-01T13:29:31", "published_display": "01 Jul 2026 13:29", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche takes on Illumina with new NGS system", "summary": "Roche is entering the next-generation sequencing market with its new Axelios 1 system, directly challenging Illumina's long-standing dominance. The Axelios 1 platform utilizes a novel \"sequencing by expansion\" (SBX) technology, which Roche claims offers improved accuracy, scalabi", "url": "https://www.medtechdive.com/news/roche-takes-on-illumina-with-new-ngs-system/824146/", "source_name": "MedTech Dive", "published_at": "2026-06-30T20:40:31", "published_display": "30 Jun 2026 20:40", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Illumina, Inc. \u2013 TURQUOISE:ILMNN", "summary": "This article displays the \"Price to earnings forward\" value for Illumina, Inc. (ILMNN) on the Turquoise market. It indicates that the market is currently closed with no trades. The data is provided by ICE Data Services and FactSet Research Systems Inc.", "url": "https://www.tradingview.com/symbols/TURQUOISE-ILMNN/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T10:41:49", "published_display": "29 Jun 2026 10:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche takes aim at Illumina's dominance with new gene sequencing machine", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNMUZtcHk0a3pVMUJ2akdyXzBZYk9waEdtN21IaHRKLUN0S1FsbVcxN21qb2hadFBQcnp5OHQ1MlRnekhYYXVoY3hza1NWWnpzdG40V3RaUDI3WVdiNnBfejl5SGxhel96blhXLURyeW9mbnpTWGNiX0RDZ1RITE94SlQ5cnlCVE1uaHIxWVFCX2VIWUxvZVdrTnVNbHczZEQ3WXNmSlZfcmZwRHVyS0l1X0Q0OXpzMEE?oc=5", "source_name": "Reuters", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche Launches AXELIOS 1 Sequencer At $750,000, Targeting Illumina\u2019s Market", "summary": "Roche has launched its new AXELIOS 1 Sequencer, priced at $750,000, directly challenging Illumina's market dominance. The sequencer is capable of generating reads up to 1,500 base pairs, positioning Roche as a significant competitor in the genomics sequencing industry. This move ", "url": "https://insights.citeline.com/medtech-insight/business/strategy/roche-launches-axelios-1-sequencer-at-750000-targeting-illuminas-market-NRUE7DGMUNEWDPFKW4R3EKPOWA/", "source_name": "insights.citeline.com", "published_at": "2026-06-29T07:13:23", "published_display": "29 Jun 2026 07:13", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh Actuals & Estimates (BMFBOVESPA:I1LM34)", "summary": "This page provides financial actuals and estimates for Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh (BMFBOVESPA:I1LM34) on TradingView. Users can explore reported financial data and analyst estimates, comparing actual results with average, high, and low est", "url": "https://www.tradingview.com/symbols/BMFBOVESPA-I1LM34/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-26T16:10:29", "published_display": "26 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Stock Is Up 32% in 2026: Has the GRAIL Recovery Already Been Priced In?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNWlpjN2RyeExiOHl1aDNkaUhZeHpvQXFPNWRJX1Y2Ukd3eVUwdTBUWExXcWhaR1dCMnBYSXhNem51bVl3dHUzazllU3VHU0ljYVZ5V2RfamNHMTF3dWN6N1NDNGYtOG45RkwwUTdldUd3STY3SThEWVE2SmZPREZtdGF6Wi1seThacXdnNHNJN3dsZWdJcnhocm1XTFN6MlA4UEpjUVFB?oc=5", "source_name": "TIKR.com", "published_at": "2026-06-26T13:30:56+00:00", "published_display": "26 Jun 2026 13:30", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Scott Davies Sells Shares of Illumina Inc (ILMN)", "summary": "Scott Davies, Chief Legal Officer of Illumina Inc's subsidiary, sold 615 shares of Illumina Inc (ILMN) on June 25, 2026. This transaction brings his total holdings to 20,953 shares. The stock is currently trading at $180, significantly above its GF Value of $129.16, indicating it", "url": "https://www.gurufocus.com/news/8932905/insider-sell-scott-davies-sells-shares-of-illumina-inc-ilmn", "source_name": "GuruFocus", "published_at": "2026-06-26T04:10:08", "published_display": "26 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (NASDAQ: ILMN) legal chief sells 615 shares in open-market trade", "summary": "Illumina's Chief Legal Officer, Scott M. Davies, sold 615 shares of the company's common stock at $180 per share in an open-market transaction. This sale, totaling $110,700, represents a small portion of his overall direct holdings, which now stand at 20,953 shares. The transacti", "url": "https://www.stocktitan.net/sec-filings/ILMN/form-4-illumina-inc-insider-trading-activity-6d04287d37fb.html", "source_name": "Stock Titan", "published_at": "2026-06-26T02:10:08", "published_display": "26 Jun 2026 02:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (NASDAQ: ILMN) affiliate files Form 144 reporting 98,400-share 10b5-1 sale", "summary": "An Illumina (NASDAQ: ILMN) affiliate has filed Form 144 to report the proposed sale of 98,400 common shares. The filing details a 10b5-1 sale on May 29, 2026, linked to Performance Stock Units and Restricted Stock Units granted on February 21, 2023. This is a regulatory notice of", "url": "https://www.stocktitan.net/sec-filings/ILMN/144-illumina-inc-sec-filing-08050a9ce2c4.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:09:45", "published_display": "25 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Frances Arnold sells Illumina shares (ILMN) in multiple May\u2013June 2026 trades", "summary": "Frances Arnold reported proposed sales of Illumina (ILMN) common stock through a Form 144 filing, detailing multiple dispositions in May\u2013June 2026. These include sales of 3,000 shares on June 2, 2026, for $484,571.70 and 5,000 shares on May 28, 2026, for $780,650.00. The filing a", "url": "https://www.stocktitan.net/sec-filings/ILMN/144-illumina-inc-sec-filing-8939223f29e6.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:09:45", "published_display": "25 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Jumps 7.7% Amid Sector-Wide Rally", "summary": "Illumina (ILMN) saw its stock surge by 7.7% on Wednesday, closing at $177.66, driven by a broad sector-wide rally in diagnostics and research stocks. This gain was part of a larger trend, with several other life sciences companies also experiencing significant increases. The rall", "url": "https://news.alphastreet.com/illumina-jumps-7-7-amid-sector-wide-rally/", "source_name": "AlphaStreet", "published_at": "2026-06-25T11:10:08", "published_display": "25 Jun 2026 11:10", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) director Daniel Skovronsky receives 1,674-share RSU grant", "summary": "Illumina director Daniel Skovronsky received a grant of 1,674 restricted stock units (RSUs), valued at $164.28 per share, representing his total direct holding after this transaction. The RSUs will vest entirely on the earlier of one year from the grant date or the date immediate", "url": "https://www.stocktitan.net/sec-filings/ILMN/form-4-illumina-inc-insider-trading-activity-57fe56c1ae9e.html", "source_name": "Stock Titan", "published_at": "2026-06-24T22:10:50", "published_display": "24 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Illumina (ILMN) Stock Is Trading Up Today", "summary": "Illumina's stock (ILMN) surged 6.6% after the company appointed Daniel M. Skovronsky, a high-profile Eli Lilly executive, to its board of directors. Barclays also increased its price target for Illumina to $145 from $122, noting that life science and diagnostic tools are gaining ", "url": "https://uk.finance.yahoo.com/news/why-illumina-ilmn-stock-trading-185625423.html", "source_name": "Market source", "published_at": "2026-06-24T18:40:05", "published_display": "24 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Stock After 80% One-Year Rebound Is The Price Now Justified", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPbEM5TV9ld2cxRjhFOWxwcVBWbXZYU3NjaFBtak8zUEl2ck40dHhrU3ptV1h0OHlVZXE4TjQ2Z20waC1jN1ZyQ0t1Rl9DWVFzTVQwa0lrcDZDREtWUFFuV3M2dnFGOGdHSDRrUW1LSXJPaDNDcVdwLS03aFMzeEVoZ0REanFMMGNraGJiLXFJa291dll2bEE?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQNWc4cG9KbU1YZ1RhMjQ3bzB0eEpvS2ZkbE5xN1NYdDhuSmlzbXVTZGlUdWxneEU4ekFuelBFX1I3Vng2cmFINU92S1VsTlJCRk5mc1J6UmFOQkV3RmVrNG1tNGR2WFlTZTNZRlQxQm9DUWxRSGI4bzNIOHZ6eGVacmRuZHp0WTVJeHJzS2ZDU2hfanA3cUdtY1lGZmJLNVZXcUNaVHlBQktLSzIwRm8zM2xVRFRrOWNJWmRNekU1RHVXUQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Stock After 88% Rebound Is The Current Price Still Attractive", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Stock\u2019s Operating Margin Climbs to 22% in Q1 2026: Is it Enough to Support a $300 Target?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNc1E1aWRuQTFQN2FSNk91Y2w2Q1hEcy1iN3dCSXNTTjdnNlg0ZXhHdlJTSmpTeVcxNDU0LW50ZURFQnFkUnVLMkVDZFItOFg0ekUtSVJLNnRsNWo5YUVLcnN6M2FZRHB0SHl2U2VDWnlVb1hFMUE0M2hnVEQtRVJ6N3Jva3N4Szc5LThIeE9yWTZZbFlpbUxLcU92Z0Y4bXVSSzhrb3NsZEZNbmJsUTEtaEdrRHRhcUsxd25Z?oc=5", "source_name": "TIKR.com", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Inc. stock (US4523271090): shares track Nasdaq ahead of next catalysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQnpGaWt3Wm02b3VqNlBpYkR1N2NUd2FJa2RfN2JDWXN4VG1DakRidVYtSkphcU5qQUlxZUZVejFDVmthaUhZd3E2Y2h6dUtCTFE5OXRPMFZTU1NPVElfdFpVZExZYm9rSGdwT3RXbzVWWW10XzhKcHo5R2dxeWYtN1FheHQydGEydVR0MjdNNlV0TmFFWktncExSb1E2ZHJHeDZJa0tVZHcwbzhGV29VQUhmTy1HeTVIMC1xSl9OMmdjQQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Inc stock (US4523271090): New MRD research launch and fresh 52-week high draw focus to valu", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNR2hUa1RZa1V4b0Q3RllaRDRzcUlqaHhqSENIeER2ZUxmRThmd0lyMnpnYjRRYlNDOXc4SHlyLWo3TmhKcWZsYmdDOGlZU1l0R2xBNnVoWVFLNEh2cmI1RU5hcXNTcGxIdmQwb1ZYTWYySUFIa2d1WndBbmJDTE1ORnhHNFhTbk51amwxSUlKVWEyZ0NZUjMzdnRkaURyRUVWQTJ1SmM2Zy1kenczR2dmeUprdFVPaDZNUEZHMzNsVWNaUQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Inc. stock (US4523271090): shares near 12-month high after new automation launch", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNRDN1VkJJVGt5clo4bWtsQUpWc1c0d0hfSDk4YU9lc0stdWJHZUExNERRYTlYRVBzVnNia1NUQTlvS0FENElwdWFuVTFSaGNyMzJJeXc0RDVKZHEtSTRqZlNlNm0xdW9CYVExUFY3NVFJTFd1Zm5nTjgydFNOOTl2QXJCRHRwczZlTkZELTRVY05RaEE2ZUhNNWxFN01uckdzSUl6QzVfRGRXdXJxOUttU2hhNnNrWG43bU04WnljTGVVeF95?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina stock (US4523271090): analysts see limited upside after volatile Nasdaq recovery", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOUTJhNGJRblhaMlNmWGVzRWRKX0Yxbzc0eld4UHBpOTUzamRMcDFjbzVWLS1keEhzT2c3LXlWR2lBYmpQbi1wMXdmZlYtR1lIdDQ0S1N4QjFyNnlVcElWSTJsSm1nT3dOdkZJWFB2Sm92YWh1MG1WM29QYmNjdFpxZFFNZWIwN1o5ajBOekRpMURMb3ktVmpISDRjUEZ1cmpoWnM5eTJHZFpyWmkxaEM1TEh5dTFadWNZc3NIRUZ5Wmtaem12SGZ5eg?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina stock (US4523271090): gene sequencing player in focus after leadership and strategy updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSXNzem5fVjdnb3FrQ3lOOVJoNXpDbDNvbFVMdXVlbC0zZEtxR0xEOGo2Y21ISDRyaVBid001MC1lY2ZZQjdwTlJ5bl9RU0VUQ1BSR3N0NjhqQzVRVlFHb3BiREhlVW1jUUZsWnVkeHJpNGF4V0t5N2tDdUpDWmZJRHRWRWhTM2pDM2lWd1V0bTNfMGk2anFhVDdiSlROWU15ZVNYMzdubHNLYUVVaVUyNUN6dzllRFg1bWNXTHFtUS15dw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina stock (US4523271090): Q1 2026 earnings beat signals recovery momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPclAxU285cW9TTWNyeDI1b2owR0M2ZVhXdkRRSkdQQk56WTdKczl5aEpxcEF2X0lPN3VWSFNMcDNNX29IMjVYX3VyLVl4SEhEbHVkdUY3SDcwSHdxYmJDR0ZydHNuQWlfNGUtYnFmcDFjU1RnS1B4cGZ4WHpOVHJ5a1RfUUExQWgtSFRLSzZ5TXdRNVY1ck1LWDJERU5ydDRDNWJrOGNMby1Zb1hrbWw5WkVuQVoxbG95azd0a0pRRFhGXzg?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) Form 144 lists 600,000 shares with Goldman Sachs broker", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQYTJpWEZvZWc2WVBzc1g1NFp3X1J0d1dRN3hqSi1NOTBPSHFhSklIaWE3T2NjTlkzcTlWak81R2xHbERrc1pzMWVuSlFNbGdLSm43dFBvSGd6SGZrUk5KS2hGb2Y3eWxxU09MTEl1UjFscU1mTEs5R0c5QUljbEpIenNYYUdaTlFRLV9UQ1JXazk1eTQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think That There Are Issues Underlying Illumina's (NASDAQ:ILMN) Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina (ILMN) One Off Gain Shapes Profitability Narrative Heading Into 2026 Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxObkN4SU95UDlrSWJvMkNGd2RoS1QwRGFMeUNoMHVxcFdCOWpSaWVEMmJ1YURra1hhcWlwSmZHT0Zpbjl3Y3RMX1FWbEhiM3VRdWtwSG1Xc1BWTURCejdlblZoS3ZCLTM4YXZ2Wl9QdTdkRF9SUDRqeUIteUNuVUVfcEVwc0RXR05lMnZBdVNURFd3MXFxc2xWSktEeFdxc0ctd1lfMTh3RmFHNzh0VmVmZmh3T2lhQUsxWGc?oc=5", "source_name": "TradingView", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Reports Financial Results for First Quarter of Fiscal Year 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOU29DWmY2MVliX294RVhkQjAwUmJWZW9Sa29MY0J6cngzN2Rod1FGRlNoN2h1NlNUNXROdkVjVDZxYVNYSXcyZjlKSFo0ZTEwZ1BveFQwRTFZR1BSb0MzSkdNa3lsd0Q5VzBnaEZmMG9MT3dfdDQxNExyZUFEeWxpVUI1eWtZUlctTjA2YzN0UnNkUy1TT19SWmtBSTlPazg2a19nQnV6M0gtcjlXUlRQUGN4Uy0yd3NzT2ZkU19SamM1enpmTDlR?oc=5", "source_name": "PR Newswire", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Stock Climbs 44.8% in a Year: What's Driving the Rally?", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5ZMDIzVmhYVEp3eHVOOFVIaFR0WmZEYU93Wlo3SEV4R09FUU9TRE93OHRJemdyVXg1dDczUGZvYU0zelZUbTZFTWVjLUdmTkNPTzlZUk9lLTROM3VMSlZzWkZlNndaTnNRUk9vRm9VRVB4cFNZTVNzd0s3Umw?oc=5", "source_name": "Market source", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GRAIL Inc. - Illumina's Divested Holy Grail (NASDAQ:GRAL)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNNHRZMFVDVlFhMTJrN0xoYlloN3pxdjItLWY0Q0s0N2ZwUHRxRkQwc0t5WGx4dmljWHpHdmQzQnFKYWt6aWFXRDkyRFhjOFczdkdTeWNoLXZkcUVQbTFxMlVJRGRKNTRYdU93YkttWFd5V3VabHRseEV0YmtNUUhIakhYa2V6QTg?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-20T08:00:00+00:00", "published_display": "20 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina, Inc. (NASDAQ:ILMN) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-09T08:00:00+00:00", "published_display": "09 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQdWE5RW5idmo0UjFRYnNjMDR4RTNLOFFwNVE5cTZsNTlyTW8xTUVDdU9nQVZkOE4zdm43b1FXYVUxR2hlUEMtZlRCZWh3WTFKWGpXS0syenktbDRyNlZiLUNLREVlMGpHZFppNzNZVzA2WXZURWZ6cXVhOFNzX0xqZUhxaVE2VjYyNkh1WFVtWjcyVldXcFNNdXZIaWlIOUFkZVRWbWV5N2lvUENGcUpjdzVmWTUzd3RIMWdsLV9JbGdPeDhQS0Y2TA?oc=5", "source_name": "PR Newswire", "published_at": "2025-07-31T07:00:00+00:00", "published_display": "31 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 108, "total_relevant": 59, "sentiment_summary": {"positive": 18, "negative": 6, "neutral": 35, "score": 54, "total": 59, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 22.1, "count": 37}, {"event": "earnings", "label": "Earnings", "weight": 7.7, "count": 14}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 18, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 186.65, "latest_week": "2026-07-17", "one_week_move": -1.9, "four_week_move": 15.3, "twelve_week_move": 46.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.378942, "market_dynamics_buy_signal": false, "relative_strength": 31.719349, "fair_value_gap": 52.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 54.1105, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.9% over one week, +15.3% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Ad-hoc-news.de", "count": 7}, {"label": "Market source", "count": 7}, {"label": "Stock Titan", "count": 7}, {"label": "PR Newswire", "count": 5}, {"label": "simplywall.st", "count": 5}, {"label": "TradingView", "count": 5}, {"label": "MarketWatch", "count": 3}, {"label": "GuruFocus", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 59}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 37}, {"label": "Earnings", "count": 14}, {"label": "Regulatory and legal", "count": 3}, {"label": "Analyst action", "count": 3}, {"label": "Guidance", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "59", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.9% over one week, +15.3% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Is Illumina Inc (ILMN) Overvalued After 4.2% Rally? GF Value Say"}], "updated_at": "2026-07-22T05:36:16.950949+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}